Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport
- 22 February 2001
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (4) , 505-513
- https://doi.org/10.1016/s0928-0987(00)00215-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.Pharmaceutical Research, 2000
- Effects of Intestinal CYP3A4 and P-Glycoprotein on Oral Drug Absorption—Theoretical ApproachPharmaceutical Research, 1999
- Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-GlycoproteinPharmaceutical Research, 1999
- In Vitro techniques for studying drug metabolismJournal of Pharmacokinetics and Biopharmaceutics, 1996
- Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco‐2) cellsBritish Journal of Pharmacology, 1996
- Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug deliveryJournal of Controlled Release, 1996
- Azelastine and flezelastine as reversing agents of multidrug resistance: Pharmacological and molecular studiesBiochemical Pharmacology, 1995
- Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamilyBiochemical Pharmacology, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cellsBritish Journal of Cancer, 1987